联环药业
(600513)
| 流通市值：23.29亿 | | | 总市值：23.29亿 |
| 流通股本：2.85亿 | | | 总股本：2.85亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,174,100,305.52 | 1,483,405,300.86 | 954,649,770.62 | 451,680,716.64 |
| 营业收入 | 2,174,100,305.52 | 1,483,405,300.86 | 954,649,770.62 | 451,680,716.64 |
| 二、营业总成本 | 2,016,158,761.63 | 1,371,969,771.26 | 882,109,946.92 | 413,066,960.92 |
| 营业成本 | 1,127,546,545.19 | 785,580,581.56 | 494,792,494.28 | 236,471,638.95 |
| 税金及附加 | 19,873,558.38 | 12,966,174.42 | 8,730,967.44 | 4,004,824.54 |
| 销售费用 | 591,602,014.6 | 390,141,987.66 | 267,530,434.99 | 117,755,468.74 |
| 管理费用 | 119,520,360.7 | 96,437,173.37 | 65,577,700.83 | 39,937,864.19 |
| 研发费用 | 132,140,716.74 | 69,041,803.18 | 33,523,002.04 | 9,520,142.33 |
| 财务费用 | 25,475,566.02 | 17,802,051.07 | 11,955,347.34 | 5,377,022.17 |
| 其中:利息费用 | 26,688,401.26 | 17,474,081.2 | 13,009,221.97 | 5,383,869.34 |
| 其中:利息收入 | 1,331,448.38 | 1,059,843.77 | 823,096.97 | 495,249.54 |
| 加:投资收益 | -421,810.19 | -1,495,910.33 | -917,052.81 | -502,850.21 |
| 资产处置收益 | 8,885,605.73 | - | - | - |
| 资产减值损失(新) | -2,555,905.5 | -506,148.05 | -633,688.7 | -54,296.55 |
| 信用减值损失(新) | -3,714,119.9 | 365,447.43 | -998,267.5 | 1,100,780.32 |
| 其他收益 | 14,636,651.11 | 7,599,085.34 | 7,486,912.54 | 2,381,166.38 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 174,771,965.14 | 117,398,003.99 | 77,477,727.23 | 41,538,555.66 |
| 加:营业外收入 | 1,779,869.97 | 265,368.36 | 264,787.26 | 264,285.76 |
| 减:营业外支出 | 1,519,778.29 | 810,879.91 | 703,082.18 | 170,865.99 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 175,032,056.82 | 116,852,492.44 | 77,039,432.31 | 41,631,975.43 |
| 减:所得税费用 | 23,691,733.11 | 16,255,478.16 | 9,337,409.95 | 6,571,467.86 |
| 六、净利润 | 151,340,323.71 | 100,597,014.28 | 67,702,022.36 | 35,060,507.57 |
| 持续经营净利润 | 151,340,323.71 | 100,597,014.28 | 67,702,022.36 | 35,060,507.57 |
| 归属于母公司股东的净利润 | 135,008,519.87 | 88,841,806.7 | 61,527,771.37 | 31,119,932.73 |
| 少数股东损益 | 16,331,803.84 | 11,755,207.58 | 6,174,250.99 | 3,940,574.84 |
| (一)基本每股收益 | 0.47 | 0.31 | 0.21 | 0.11 |
| (二)稀释每股收益 | 0.47 | 0.31 | 0.21 | 0.11 |
| 八、其他综合收益 | -195,308.71 | - | - | - |
| 归属于母公司股东的其他综合收益 | -195,308.71 | - | - | - |
| 九、综合收益总额 | 151,145,015 | 100,597,014.28 | 67,702,022.36 | 35,060,507.57 |
| 归属于母公司股东的综合收益总额 | 134,813,211.16 | 88,841,806.7 | 61,527,771.37 | 31,119,932.73 |
| 归属于少数股东的综合收益总额 | 16,331,803.84 | 11,755,207.58 | 6,174,250.99 | 3,940,574.84 |
| 公告日期 | 2024-03-06 | 2023-10-31 | 2023-08-26 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | | | |